We have used a primary B-cell model to determine how progressively increased MYC levels drive cells, which are otherwise predisposed for oncogenic transformation, into a lymphoma phenotype, as well as how this process is augmented by lymphoma-associated mutations affecting the MYC protein. The gene discussed is MYC; the disease is lymphoma.